Systolic hypertension: an increasing clinical challenge in Asia

Area of Science:

• Gerontology
• Cardiovascular Medicine
• Vascular Biology

Background:

• Systolic hypertension is prevalent in individuals over 50-60 years, particularly in aging Asian populations.
• Age-related vascular changes lead to arterial stiffening, the primary cause of elevated systolic blood pressure.
• Elevated systolic pressure increases risks for cardiovascular disease, mortality, and renal decline, with potentially lower thresholds in Asian individuals.

Purpose of the Study:

• To highlight the growing issue of systolic hypertension in aging Asian populations.
• To underscore the inadequacy of current blood pressure control and treatments.
• To emphasize the need for novel therapeutic strategies targeting arterial stiffening.

Main Methods:

• This study is a review of current literature on systolic hypertension, arterial stiffening, and antihypertensive treatments.
• Analysis of epidemiological data concerning hypertension prevalence in aging Asian populations.
• Evaluation of the limitations of existing antihypertensive medications in addressing the pathophysiology of systolic hypertension.

Main Results:

• Systolic hypertension is a significant health issue in aging Asian populations, driven by arterial stiffening.
• Blood pressure control remains suboptimal due to factors including low awareness, under-treatment, and drug tolerability issues.
• Existing antihypertensive drugs do not effectively target the underlying vascular pathology of arterial stiffening.

Conclusions:

• Effective systolic pressure lowering is critical for Asian populations, necessitating improved blood pressure management.
• Novel pharmacological approaches are required to address the pathophysiology of arterial stiffening in systolic hypertension.
• Optimal management of systolic hypertension and its complications demands treatments that target underlying vascular changes.